Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

The role of chromatin remodeling in medulloblastoma.

Jones DT, Northcott PA, Kool M, Pfister SM.

Brain Pathol. 2013 Mar;23(2):193-9. doi: 10.1111/bpa.12019. Review.

PMID:
23432644
[PubMed - indexed for MEDLINE]
2.

Signaling pathway and molecular subgroups of medulloblastoma.

Li KK, Lau KM, Ng HK.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1211-22. Print 2013. Review.

PMID:
23826403
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.

Manoranjan B, Wang X, Hallett RM, Venugopal C, Mack SC, McFarlane N, Nolte SM, Scheinemann K, Gunnarsson T, Hassell JA, Taylor MD, Lee C, Triscott J, Foster CM, Dunham C, Hawkins C, Dunn SE, Singh SK.

Stem Cells. 2013 Jul;31(7):1266-77. doi: 10.1002/stem.1401.

PMID:
23592496
[PubMed - indexed for MEDLINE]
4.

Dissecting the genomic complexity underlying medulloblastoma.

Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber UD, Wang Q, Lasitschka B, Bartholomae CC, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts MJ, Russell RB, Coco S, Tonini GP, Schüller U, Hans V, Graf N, Kim YJ, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, von Deimling A, Witt O, Maass E, Rössler J, Ebinger M, Schuhmann MU, Frühwald MC, Hasselblatt M, Jabado N, Rutkowski S, von Bueren AO, Williamson D, Clifford SC, McCabe MG, Collins VP, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott PA, Taylor MD, Meyerson M, Pomeroy SL, Yaspo ML, Korbel JO, Korshunov A, Eils R, Pfister SM, Lichter P.

Nature. 2012 Aug 2;488(7409):100-5. doi: 10.1038/nature11284.

PMID:
22832583
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Medulloblastoma comprises four distinct molecular variants.

Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD.

J Clin Oncol. 2011 Apr 10;29(11):1408-14. doi: 10.1200/JCO.2009.27.4324. Epub 2010 Sep 7.

PMID:
20823417
[PubMed - indexed for MEDLINE]
Free Article
6.

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.

Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R.

PLoS One. 2008 Aug 28;3(8):e3088. doi: 10.1371/journal.pone.0003088.

PMID:
18769486
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.

Lau KM, Chan QK, Pang JC, Ma FM, Li KK, Yeung WW, Cheng AS, Feng H, Chung NY, Li HM, Zhou L, Wang Y, Mao Y, Ng HK.

Acta Neuropathol. 2012 Apr;123(4):553-71. doi: 10.1007/s00401-011-0934-8. Epub 2012 Jan 17.

PMID:
22249617
[PubMed - indexed for MEDLINE]
8.

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.

Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ.

J Clin Oncol. 2006 Apr 20;24(12):1924-31. Epub 2006 Mar 27.

PMID:
16567768
[PubMed - indexed for MEDLINE]
Free Article
9.

Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.

Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG, Croul SE.

Brain Pathol. 2013 Mar;23(2):178-91. doi: 10.1111/j.1750-3639.2012.00631.x. Epub 2012 Oct 11.

PMID:
22966790
[PubMed - indexed for MEDLINE]
10.

Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.

Korshunov A, Remke M, Kool M, Hielscher T, Northcott PA, Williamson D, Pfaff E, Witt H, Jones DT, Ryzhova M, Cho YJ, Wittmann A, Benner A, Weiss WA, von Deimling A, Scheurlen W, Kulozik AE, Clifford SC, Peter Collins V, Westermann F, Taylor MD, Lichter P, Pfister SM.

Acta Neuropathol. 2012 Apr;123(4):515-27. doi: 10.1007/s00401-011-0918-8. Epub 2011 Dec 9.

PMID:
22160402
[PubMed - indexed for MEDLINE]
11.

Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.

Al-Halabi H, Nantel A, Klekner A, Guiot MC, Albrecht S, Hauser P, Garami M, Bognar L, Kavan P, Gerges N, Shirinian M, Roberge D, Muanza T, Jabado N.

Acta Neuropathol. 2011 Feb;121(2):229-39. doi: 10.1007/s00401-010-0780-0. Epub 2010 Nov 24.

PMID:
21107850
[PubMed - indexed for MEDLINE]
12.

Medulloblastoma molecular dissection: the way toward targeted therapy.

Remke M, Ramaswamy V, Taylor MD.

Curr Opin Oncol. 2013 Nov;25(6):674-81. doi: 10.1097/CCO.0000000000000008. Review.

PMID:
24076581
[PubMed - indexed for MEDLINE]
13.

Development and cancer of the cerebellum.

Hatten ME, Roussel MF.

Trends Neurosci. 2011 Mar;34(3):134-42. doi: 10.1016/j.tins.2011.01.002. Review.

PMID:
21315459
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.

Milde T, Lodrini M, Savelyeva L, Korshunov A, Kool M, Brueckner LM, Antunes AS, Oehme I, Pekrun A, Pfister SM, Kulozik AE, Witt O, Deubzer HE.

J Neurooncol. 2012 Dec;110(3):335-48. doi: 10.1007/s11060-012-0978-1. Epub 2012 Oct 6.

PMID:
23054560
[PubMed - indexed for MEDLINE]
15.

Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.

Holthouse DJ, Dallas PB, Ford J, Fabian V, Murch AR, Watson M, Wong G, Bertram C, Egli S, Baker DL, Kees UR.

Neuropathology. 2009 Aug;29(4):398-409. doi: 10.1111/j.1440-1789.2008.00989.x. Epub 2008 Dec 11.

PMID:
19077040
[PubMed - indexed for MEDLINE]
16.

Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Sardi I, Cavalieri D, Massimino M.

Paediatr Drugs. 2007;9(2):81-96. Review.

PMID:
17407364
[PubMed - indexed for MEDLINE]
17.

Medulloblastoma stem cells: modeling tumor heterogeneity.

Manoranjan B, Venugopal C, McFarlane N, Doble BW, Dunn SE, Scheinemann K, Singh SK.

Cancer Lett. 2013 Sep 10;338(1):23-31. doi: 10.1016/j.canlet.2012.07.010. Epub 2012 Jul 14. Review.

PMID:
22796365
[PubMed - indexed for MEDLINE]
18.

A molecular fingerprint for medulloblastoma.

Lee Y, Miller HL, Jensen P, Hernan R, Connelly M, Wetmore C, Zindy F, Roussel MF, Curran T, Gilbertson RJ, McKinnon PJ.

Cancer Res. 2003 Sep 1;63(17):5428-37.

PMID:
14500378
[PubMed - indexed for MEDLINE]
Free Article
19.

Novel mutations target distinct subgroups of medulloblastoma.

Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, Phoenix TN, Hedlund E, Wei L, Zhu X, Chalhoub N, Baker SJ, Huether R, Kriwacki R, Curley N, Thiruvenkatam R, Wang J, Wu G, Rusch M, Hong X, Becksfort J, Gupta P, Ma J, Easton J, Vadodaria B, Onar-Thomas A, Lin T, Li S, Pounds S, Paugh S, Zhao D, Kawauchi D, Roussel MF, Finkelstein D, Ellison DW, Lau CC, Bouffet E, Hassall T, Gururangan S, Cohn R, Fulton RS, Fulton LL, Dooling DJ, Ochoa K, Gajjar A, Mardis ER, Wilson RK, Downing JR, Zhang J, Gilbertson RJ.

Nature. 2012 Aug 2;488(7409):43-8. doi: 10.1038/nature11213.

PMID:
22722829
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.

Marchetti D, Mrak RE, Paulsen DD, Sinnappah-Kang ND.

J Exp Clin Cancer Res. 2007 Mar;26(1):5-23.

PMID:
17550129
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk